DFFVX | RSPKX | DFFVX / RSPKX | |
Total Expense Ratio | 0.29 | 1.69 | 17% |
Annual Report Gross Expense Ratio | 0.30 | 2.42 | 12% |
Fund Existence | 25 years | 19 years | - |
Gain YTD | 2.008 | -1.058 | -190% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 13.3B | 538M | 2,472% |
Annual Yield % from dividends | 1.63 | 0.03 | 4,800% |
Returns for 1 year | 3.20 | -3.75 | -85% |
Returns for 3 years | 31.44 | 8.00 | 393% |
Returns for 5 years | 105.01 | 39.35 | 267% |
Returns for 10 years | 67.93 | -15.69 | -433% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DULL | 3.92 | 0.11 | +2.89% |
MicroSectors™ Gold -3X Inverse Lvrgd ETN | |||
DHY | 2.13 | 0.02 | +0.95% |
Credit Suisse High Yield | |||
IJH | 64.36 | 0.56 | +0.88% |
iShares Core S&P Mid-Cap ETF | |||
VCEB | 63.12 | 0.16 | +0.25% |
Vanguard ESG US Corporate Bond ETF | |||
BIB | 52.55 | -0.07 | -0.14% |
ProShares Ultra Nasdaq Biotechnology |